Updated Jul 17, 2026
Dananberg Jamie is a corporate insider tracked by InsiderAlpha. No SEC Form 4 filings recorded in the last 90 days. Lifetime open-market sales: $59K.
Jamie Dananberg is associated with Annexon, Inc., a biotechnology company focused on developing therapies for neurodegenerative diseases. Specific details about their role or contributions are not widely documented in public sources.
| Role | Insider |
|---|---|
| Notability | 10/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-03-04 | ANNX | Annexon, Inc. | S — Open-market sale | 5.8K | $5.43 | $32K |
| 2026-02-24 | ANNX | Annexon, Inc. | A — Grant or award | 56.2K | $0.00 | |
| 2026-02-20 | ANNX | Annexon, Inc. | S — Open-market sale | 5.3K | $5.10 | $27K |
Jamie Dananberg is associated with Annexon, Inc., a biotechnology company focused on developing therapies for neurodegenerative diseases. Specific details about their role or contributions are not widely documented in public sources.…
Recorded transactions: 0 open-market purchases () and 2 open-market sales ($59K) across all tracked filings.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Dananberg Jamie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.